Kalshi Turns Clinical Trial Results And FDA Rulings Into Bets
AppliedXL supplies resolution data for the first contracts: AR1001's Alzheimer's trial and Gilead/Arcellx's anito-cel myeloma decision.
- AppliedXL resolves contracts using publicly registered trial filings, not any drug company's internal data.
- Launch contracts track AR1001's Alzheimer's Phase 3 trial and Gilead/Arcellx's anito-cel myeloma FDA decision.
- Kalshi verifies trader employment and lists markets only after enrollment closes, citing existing insider trading bans.
Why it matters: A market that prices what regulators won't disclose turns institutional silence into a tradable asset.
Kalshi (news.kalshi.com official announcement) ↗ · Jul 17, 20267/17/26 · ✓ Checked✓ Check